Vitamin B12 and Brain Health: Why B12 Matters for Memory, Cognition and Healthy Ageing
When we think about vitamin B12, we often associate it with energy, red blood cells and nerve health. But B12 is also critically important for the brain.
Vitamin B12 is involved in DNA synthesis, myelin production, methylation and the metabolism of homocysteine — processes that are essential for maintaining healthy neurons and normal neurological function.
Importantly, B12 deficiency can present with neurological and cognitive symptoms, sometimes even when a person is not anaemic. Symptoms can include brain fog, poor concentration, memory problems, confusion, mood changes, numbness or tingling and difficulties with balance.
And there is an important distinction in the research:
Correcting genuine B12 deficiency can improve neurological and cognitive symptoms in some people — particularly when treatment occurs early.
Why does the brain need vitamin B12?
B12 plays several important roles in neurological health.
1. It helps maintain myelin
Myelin is the protective coating surrounding many nerve fibres. It allows electrical signals to travel efficiently through the nervous system.
B12 deficiency can interfere with myelin formation and maintenance, which helps explain why neurological symptoms such as tingling, numbness, balance problems and cognitive changes can occur with deficiency.
2. It helps regulate homocysteine
Vitamin B12 works alongside folate and vitamin B6 in pathways that metabolise homocysteine.
When B12 is insufficient, homocysteine can rise.
Elevated homocysteine has been associated with vascular and neurological changes, including brain atrophy and cognitive impairment. Researchers have proposed several mechanisms through which elevated homocysteine could affect the brain, including vascular injury, oxidative stress and impaired methylation.
3. It supports methylation
B12 is required for the conversion of homocysteine to methionine, which ultimately contributes to the production of S-adenosylmethionine (SAMe), a major methyl donor in the body.
Methylation reactions are involved in numerous neurological processes, including neurotransmitter metabolism, membrane function and gene regulation.
This is one reason that B12 status is particularly relevant to long-term neurological health.
Can low B12 actually affect memory and cognition?
There is a substantial body of research connecting low B12 status with cognitive impairment.
A review published in the American Journal of Clinical Nutrition found that cognitive performance can be associated with B12 status even at concentrations above traditional definitions of deficiency. The authors discussed possible links between low B12 status, brain atrophy and white-matter damage.
Another review examining 43 studies found that B12 levels below approximately 250 pmol/L were associated with Alzheimer's disease, vascular dementia and Parkinson's disease, while more severe deficiency was associated with cognitive impairment. Importantly, the authors concluded that cognitive improvement following B12 treatment was most evident in people with pre-existing deficiency, rather than people with normal B12 status.
However, association does not automatically mean causation.
This distinction is important because dementia is a complex condition with many contributing factors. Low B12 may sometimes be a contributing factor, a consequence of poor nutrition or illness, or simply occur alongside other risk factors.
What happens when B12 deficiency is corrected?
This is where the research becomes particularly interesting.
Several studies have reported improvements in cognitive testing following B12 replacement in people who were deficient.
Study: cognitive recovery after B12 replacement
One study investigated patients with dementia and low B12 levels. After at least 12 months of B12 treatment, 40 of 56 patients showed cognitive improvement.
The response appeared to depend partly on how long cognitive symptoms had been present.
Patients whose symptoms had been present for less than 12 months improved by an average of 6 points on the Mini-Mental State Examination (MMSE), compared with an average improvement of 4 points among those whose symptoms had lasted longer than 12 months.
The authors suggested that there may be a time-limited window in which correcting B12 deficiency is more likely to produce meaningful neurological recovery.
Another study: dramatic improvement in early symptoms
An earlier pilot study looked at people with cognitive impairment and B12 deficiency who received intensive B12 replacement.
After at least six months of treatment, 11 of 18 participants demonstrated cognitive improvement.
The most striking finding was the relationship between the duration of symptoms and recovery.
Those who had experienced symptoms for less than 12 months improved by an average of 20 points on the Mattis Dementia Rating Scale, while those with symptoms lasting longer than 12 months did not show the same improvement.
This supports an important clinical concept:
The earlier an underlying B12 deficiency is identified and corrected, the greater the potential for neurological recovery.
More recent evidence
A 2022 multicentre study looked specifically at people with cognitive impairment and confirmed B12 deficiency.
The study included 39 patients who received B12 supplementation and were reassessed after treatment.
Their average MMSE score increased from 20.5 to 22.9, while homocysteine levels decreased substantially. The improvement in MMSE was statistically significant.
This is particularly interesting because the study looked at people who had both cognitive impairment and biochemical B12 deficiency, rather than simply giving B12 to people with normal B12 levels.
But can B12 reverse dementia?
This is where we need to be careful.
B12 deficiency can cause cognitive and neurological symptoms that may be partially or substantially reversible. However, B12 should not be considered a treatment for Alzheimer's disease or other forms of established neurodegenerative dementia unless B12 deficiency is present.
Research in people with established dementia has produced mixed results.
For example, a study of patients with dementia and B12 deficiency found that some people with mild, relatively recent dementia returned to normal MMSE scores following B12 replacement, while most patients continued to decline.
Another study found that B12 treatment did not significantly improve neuropsychological function in patients who already had dementia, but patients with cognitive impairment — rather than established dementia — showed improvement in verbal fluency.
This suggests that B12 deficiency may be particularly important as a potentially reversible contributor to cognitive impairment, rather than being a universal cause of dementia.
Why the research can appear contradictory
You may have seen headlines saying that B12 does not improve memory or prevent dementia.
There is truth to this — particularly when looking at people who are not B12 deficient.
Large randomised trials have generally not shown that simply giving B12, folate or other B vitamins to older adults with adequate nutritional status dramatically improves cognition or prevents dementia. The NIH's current evidence review similarly concludes that supplementation has not consistently improved cognition in older adults with or without dementia.
However, this is different from asking:
"What happens when someone who is genuinely B12 deficient has their deficiency corrected?"
That question has produced more encouraging results.
A 2025 systematic review and meta-analysis of 17 randomised controlled trials involving 5,275 older adults found a small overall benefit of B-vitamin supplementation on global cognitive function. After removing statistical outliers, the effect was smaller but remained statistically significant. However, the authors noted that the evidence relates to B vitamins collectively — B6, B9 and B12 — rather than B12 alone.
So the evidence does not support the claim that everyone should take high-dose B12 to prevent dementia.
It does support the importance of identifying and correcting B12 deficiency, particularly when neurological or cognitive symptoms are present.
Who is more likely to become B12 deficient?
B12 deficiency becomes more common with age and can occur for reasons beyond simply not eating enough B12.
People at increased risk can include those with:
Low intake of animal products
Vegetarian or vegan diets
Reduced stomach acid
Gastric or intestinal disorders
Previous gastrointestinal surgery
Certain medications, including metformin
Long-term use of acid-suppressing medications
Malabsorption conditions
Older adults
Interestingly, a person can have a normal haemoglobin and MCV while still having clinically relevant B12 deficiency. This means that looking only at a standard full blood count may not be enough to exclude B12-related neurological problems.
B12 levels: is the standard blood test enough?
Not always.
Serum B12 is useful, but it does not always tell the whole story.
When B12 status is uncertain, clinicians may also consider functional markers such as:
Methylmalonic acid (MMA)
and
Homocysteine
MMA rises when intracellular B12 availability is insufficient and can therefore provide additional information about functional B12 status.
Homocysteine can also rise with B12 deficiency, although it is less specific because folate and vitamin B6 status, kidney function and other factors can influence it.
This is one reason why a person with neurological symptoms and a "borderline" B12 result may warrant a more complete assessment rather than simply being told that their B12 is normal.
The take-home message
Vitamin B12 isn't simply an "energy vitamin."
It is a fundamental nutrient for the nervous system and is involved in myelin production, methylation, DNA synthesis and homocysteine metabolism.
The research suggests that:
✓ B12 deficiency can contribute to neurological and cognitive symptoms.
✓ Cognitive impairment associated with B12 deficiency can sometimes improve after B12 replacement.
✓ Earlier treatment appears to be associated with a greater likelihood of cognitive recovery in some studies.
✓ Some patients with mild or recent cognitive impairment have experienced substantial improvements in cognitive scores after B12 replacement.
✗ B12 supplementation does not appear to prevent or reverse dementia in people who are not B12 deficient.
✗ B12 should not be considered a standalone treatment for Alzheimer's disease or other neurodegenerative dementias.
The most important message is therefore not "take more B12."
It is:
Don't overlook B12 deficiency when investigating cognitive decline.
Because unlike many causes of cognitive impairment, B12 deficiency is identifiable and potentially treatable — and in some people, correcting it can make a meaningful difference.
If you are experiencing unexplained brain fog, memory changes, poor concentration, numbness, tingling, balance problems or other neurological symptoms, it may be worth discussing B12 status and appropriate testing with your healthcare professional.
Key research
Smith AD, Refsum H. Vitamin B-12 and cognition in the elderly. American Journal of Clinical Nutrition. 2009.
Eastley R, et al. Vitamin B12 deficiency in dementia and cognitive impairment: the effects of treatment on neuropsychological function. International Journal of Geriatric Psychiatry. 2000.
Martin DC, et al. Prevalence of vitamin B12 deficiency among demented patients and cognitive recovery with cobalamin replacement. Journal of the American Geriatrics Society. 2002.
Hvas AM, et al. Time dependency of cognitive recovery with cobalamin replacement. 1990s pilot study.
Kwak et al. Influences of Vitamin B12 Supplementation on Cognition and Homocysteine in Patients with Vitamin B12 Deficiency and Cognitive Impairment. 2022.
2025 systematic review and meta-analysis of B-vitamin supplementation and global cognitive function in older adults.
